Masakazu Amari

Sendai, 9800803, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapy.

Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapy.

Journal: Breast cancer research and treatment
Published: August 22, 2024

Granular Cell Tumor Mimicking Breast Carcinoma: A Report of Two Cases.

Granular Cell Tumor Mimicking Breast Carcinoma: A Report of Two Cases.

Journal: Cureus
Published: April 02, 2024

Granulocyte-Colony Stimulating Factor (G-CSF)-Induced Aortitis: A Case Report.

Granulocyte-Colony Stimulating Factor (G-CSF)-Induced Aortitis: A Case Report.

Journal: Cureus
Published: February 24, 2024

Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer.

Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer.

Journal: Cancer medicine
Published: November 04, 2023

Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.

Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.

Journal: Breast cancer research and treatment
Published: September 25, 2023

Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy.

Risk factors for late recurrence and postrelapse survival in estrogen receptor (ER)-positive, human epidermal growth factor receptor (HER) 2-negative breast cancer after 5 years of endocrine therapy.

Journal: Breast (Edinburgh, Scotland)
Published: June 30, 2023

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism.

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism.

Journal: Scientific reports
Published: August 08, 2020

Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.

Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.

Journal: Surgical oncology
Published: August 26, 2016

Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment.

Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment.

Journal: British journal of cancer
Published: March 15, 2013

Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.

Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.

Journal: Cancer science
Published: March 11, 2013

Development of silica-coated silver iodide nanoparticles and their biodistribution.

Development of silica-coated silver iodide nanoparticles and their biodistribution.

Journal: The Tohoku journal of experimental medicine
Published: November 08, 2012

Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.

Effect of screening mammography on cumulative survival of Japanese women aged 40-69 years with breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: October 09, 2012
Showing 1-12 of 17

Last Updated: 09/26/2026